Noninvasive Assessment of Hemodynamic Stress Distribution after Indirect Revascularization for Pediatric Moyamoya Vasculopathy

References

1. 1.↵
   2. Kuroda S,
   3. Houkin K

   . Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008;7:1056–66 doi:10.1016/S1474-4422(08)70240-0 pmid:18940695

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Scott RM,
   3. Smith ER

   . Moyamoya disease and Moyamoya syndrome. N Engl J Med 2009;360:1226–37 doi:10.1056/NEJMra0804622 pmid:19297575

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Tortora D,
   3. Severino M,
   4. Accogli A, et al

   . Moyamoya vasculopathy in PHACE syndrome: six new cases and review of the literature. World Neurosurg 2017;108:291–302 doi:10.1016/j.wneu.2017.08.176 pmid:28887276

   CrossRefPubMed
4. 4.↵
   2. Hu J,
   3. Luo J,
   4. Chen Q

   . The susceptibility pathogenesis of Moyamoya disease. World Neurosurg 2017;101:731–41 doi:10.1016/j.wneu.2017.01.083 pmid:28153617

   CrossRefPubMed
5. 5.↵
   2. Lee M,
   3. Zaharchuk G,
   4. Guzman R, et al

   . Quantitative hemodynamic studies in Moyamoya disease: a review. Neurosurg Focus 2009;26:E5 doi:10.3171/2009.1.FOCUS08300 pmid:19335131

   CrossRefPubMed
6. 6.↵
   2. Kim SK,
   3. Wang KC,
   4. Oh CW, et al

   . Evaluation of cerebral hemodynamics with perfusion MRI in childhood Moyamoya disease. Pediatr Neurosurg 2003;38:68–75 doi:10.1159/000068050 pmid:12566838

   CrossRefPubMed
7. 7.↵
   2. Yun TJ,
   3. Cheon JE,
   4. Na DG, et al

   . Childhood Moyamoya disease: quantitative evaluation of perfusion MR imaging—correlation with clinical outcome after revascularization surgery. Radiology 2009;251:216–23 doi:10.1148/radiol.2511080654 pmid:19332853

   CrossRefPubMed
8. 8.↵
   2. Lee SK,
   3. Kim DI,
   4. Jeong EK, et al

   . Postoperative evaluation of Moyamoya disease with perfusion-weighted MR imaging: initial experience. AJNR Am J Neuroradiol 2003;24:741–47 pmid:12695215

   Abstract/FREE Full Text
9. 9.↵
   2. Ogasawara K,
   3. Tomitsuka N,
   4. Kobayashi M, et al

   . Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity: case report. Neurol Med Chir (Tokyo) 2006;46:161–63 doi:10.2176/nmc.46.161 pmid:16565588

   CrossRefPubMed
10. 10.↵
    2. Saito H,
    3. Ogasawara K,
    4. Suzuki T, et al

    . Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases. Neurol Med Chir (Tokyo) 2011;51:479–83 doi:10.2176/nmc.51.479 pmid:21785240

    CrossRefPubMed
11. 11.↵
    2. Gallerani M,
    3. Manzoli N,
    4. Fellin R, et al

    . Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide. Am J Emerg Med 2002;20:371–72 doi:10.1053/ajem.2002.33774 pmid:12098191

    CrossRefPubMed
12. 12.↵
    2. Kashiwagi S,
    3. Yamashita T,
    4. Katoh S, et al

    . Regression of Moyamoya vessels and hemodynamic changes after successful revascularization in childhood Moyamoya disease. Acta Neurol Scand Suppl 1996;93:85–88 doi:10.1111/j.1600-0404.1996.tb00557.x pmid:8686450

    CrossRefPubMed
13. 13.↵
    2. Takahashi S,
    3. Tanizaki Y,
    4. Kimura H, et al

    . Hemodynamic stress distribution reflects ischemic clinical symptoms of patients with Moyamoya disease. Clin Neurol Neurosurg 2015;138:104–10 doi:10.1016/j.clineuro.2015.08.010 pmid:26318361

    CrossRefPubMed
14. 14.↵
    2. Schubert GA,
    3. Czabanka M,
    4. Seiz M, et al

    . Perfusion characteristics of Moyamoya disease: an anatomically and clinically oriented analysis and comparison. Stroke 2014;45:101–06 doi:10.1161/STROKEAHA.113.003370 pmid:24193795

    Abstract/FREE Full Text
15. 15.↵
    2. Laiwalla AN,
    3. Kurth F,
    4. Leu K, et al

    . Evaluation of encephaloduroarteriosynangiosis efficacy using probabilistic independent component analysis applied to dynamic susceptibility contrast perfusion MRI. AJNR Am J Neuroradiol 2017;38:507–14 doi:10.3174/ajnr.A5041 pmid:28104642

    Abstract/FREE Full Text
16. 16.↵
    2. Kinugasa K,
    3. Mandai S,
    4. Kamata I, et al

    . Surgical treatment of Moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms. Neurosurgery 1993;32:527–31 doi:10.1227/00006123-199304000-00006 pmid:8474642

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Ostergaard L,
    3. Sorensen AG,
    4. Kwong KK, et al

    . High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726–36 doi:10.1002/mrm.1910360511 pmid:8916023

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Yun TJ,
    3. Paeng JC,
    4. Sohn CH, et al

    . Monitoring cerebrovascular reactivity through the use of arterial spin labeling in patients with Moyamoya disease. Radiology 2016;278:205–13 doi:10.1148/radiol.2015141865 pmid:26197057

    CrossRefPubMed
19. 19.↵
    2. Jenkinson M,
    3. Beckmann CF,
    4. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Mutsaerts HJ,
    3. van Dalen JW,
    4. Heijtel DF, et al

    . Cerebral perfusion measurements in elderly with hypertension using arterial spin labeling. PLoS One 2015;10:e0133717 doi:10.1371/journal.pone.0133717 pmid:26241897

    CrossRefPubMed
21. 21.↵
    2. Nakamura M,
    3. Imai H,
    4. Konno K, et al

    . Experimental investigation of encephalomyosynangiosis using gyrencephalic brain of the miniature pig: histopathological evaluation of dynamic reconstruction of vessels for functional anastomosis—laboratory investigation. J Neurosurg Pediatr 2009;3:488–95 doi:10.3171/2008.6.PEDS0834 pmid:19485733

    CrossRefPubMed
22. 22.↵
    2. Pandey P,
    3. Steinberg GK

    . Outcome of repeat revascularization surgery for Moyamoya disease after an unsuccessful indirect revascularization: clinical article. J Neurosurg 2011;115:328–36 doi:10.3171/2011.3.JNS101908 pmid:21529138

    CrossRefPubMed
23. 23.↵
    2. Hayashi T,
    3. Shirane R,
    4. Tominaga T

    . Additional surgery for postoperative ischemic symptoms in patients with Moyamoya disease: the effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure—technical case report. Neurosurgery 2009;64:E195–96; discussion E196 doi:10.1227/01.NEU.0000336311.60660.26 pmid:19145147

    CrossRefPubMed
24. 24.↵
    2. Fujimura M,
    3. Niizuma K,
    4. Endo H, et al

    . Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for Moyamoya disease. Neurol Res 2015;37:131–38 doi:10.1179/1743132814Y.0000000432 pmid:25082550

    CrossRefPubMed